Legal analysis: China's drug registration and management measures for non-prescription drugs in the application for marketing authorization to make clear provisions, (a) the territory has the same active ingredient, indications (or functional mainstays), dosage forms, specifications of non-prescription drugs listed drugs, (b) the State Drug Administration to determine the non-prescription drugs to change the dosage form or specifications, but does not change the indications (or functional mainstays), the dose and route of administration of drugs; (c) the use of the State Drug Administration to determine the active ingredient of non-prescription drugs composed of new compound preparations; (d) other directly to the Drug Administration filed a report. (b) the State Drug Administration to determine the non-prescription drugs to change the dosage form or specifications, but does not change the indications (or functional mainstay), dosage, and the route of administration of drugs; (c) the use of the State Drug Administration to determine the non-prescription drugs of the active ingredients of the composition of the new compound preparation; (d) other direct declaration of non-prescription drugs on the list of licenses. Aloe vera plant extract whether there is a record in the Drug Administration can be directly to the official website or directly ask the business.

Legal basis: "Measures for the Administration of Drug Registration" Article 36 In one of the following cases, you can directly file an application for marketing authorization of non-prescription drugs:

(a) the territory has the same active ingredient, indications (or function), dosage form, specifications of non-prescription drugs listed on the market of pharmaceutical products;

(b) by the State Drug Administration to determine the non-prescription drug Change the dosage form or specifications, but does not change the indications (or functional mainstay), the dose and the route of administration of drugs;

(C) the use of the State Drug Administration to determine the non-prescription drugs of the active ingredients of the composition of the new compound preparations;

(D) other direct declaration of non-prescription drugs listed on the license situation.